Nemaura Medical Inc
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factor… Read more
Nemaura Medical Inc (NMRD) - Net Assets
Latest net assets as of December 2023: $-17.83 Million USD
Based on the latest financial reports, Nemaura Medical Inc (NMRD) has net assets worth $-17.83 Million USD as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.17 Million) and total liabilities ($23.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-17.83 Million |
| % of Total Assets | -344.87% |
| Annual Growth Rate | N/A |
| 5-Year Change | -630.52% |
| 10-Year Change | -3259.72% |
| Growth Volatility | 887.39 |
Nemaura Medical Inc - Net Assets Trend (2013–2023)
This chart illustrates how Nemaura Medical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nemaura Medical Inc (2013–2023)
The table below shows the annual net assets of Nemaura Medical Inc from 2013 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-03-31 | $-11.81 Million | -2634.78% |
| 2022-03-31 | $466.08K | -94.42% |
| 2021-03-31 | $8.36 Million | +736.60% |
| 2020-03-31 | $-1.31 Million | -158.96% |
| 2019-03-31 | $2.23 Million | -45.83% |
| 2018-03-31 | $4.11 Million | -23.40% |
| 2017-03-31 | $5.37 Million | -30.11% |
| 2016-03-31 | $7.68 Million | +937.00% |
| 2015-03-31 | $-917.41K | -345.36% |
| 2014-03-31 | $373.90K | +121.47% |
| 2013-03-31 | $-1.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nemaura Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4971955400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $28.90K | % |
| Other Comprehensive Income | $-959.26K | % |
| Other Components | $40.99 Million | % |
| Total Equity | $-11.81 Million | 100.00% |
Nemaura Medical Inc Competitors by Market Cap
The table below lists competitors of Nemaura Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bank of Tianjin Co Ltd
STU:B95
|
$2.49K |
|
EFG Hermes Pakistan Ltd
KAR:EFGH
|
$2.49K |
|
Son Ha Development of Renewable Energy JSC
VN:SHE
|
$2.49K |
|
SF REIT UTS
F:8ET
|
$2.49K |
|
Egyptians Real Estate Fund Certificates
EGX:EGREF
|
$2.49K |
|
Alphanam M&E
VN:AME
|
$2.48K |
|
HHGregg Inc. (IN)
PINK:HGGG
|
$2.48K |
|
creditshelf Aktiengesellschaft
F:CSQ
|
$2.48K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nemaura Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 466,084 to -11,814,198, a change of -12,280,282 (-2634.8%).
- Net loss of 14,143,735 reduced equity.
- New share issuances of 8,394,056 increased equity.
- Other comprehensive income decreased equity by 836,945.
- Other factors decreased equity by 5,693,658.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-14.14 Million | -119.72% |
| Share Issuances | $8.39 Million | +71.05% |
| Other Comprehensive Income | $-836.95K | -7.08% |
| Other Changes | $-5.69 Million | -48.19% |
| Total Change | $- | -2634.78% |
Book Value vs Market Value Analysis
This analysis compares Nemaura Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-03-31 | $0.01 | $0.00 | x |
| 2014-03-31 | $0.00 | $0.00 | x |
| 2015-03-31 | $0.00 | $0.00 | x |
| 2016-03-31 | $0.04 | $0.00 | x |
| 2017-03-31 | $0.03 | $0.00 | x |
| 2018-03-31 | $0.03 | $0.00 | x |
| 2019-03-31 | $0.12 | $0.00 | x |
| 2020-03-31 | $-0.06 | $0.00 | x |
| 2021-03-31 | $0.38 | $0.00 | x |
| 2022-03-31 | $0.02 | $0.00 | x |
| 2023-03-31 | $-0.47 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nemaura Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -18358.00%
- • Asset Turnover: 0.01x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-347.83%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -321.77% | 0.00% | 0.00x | 1.00x | $-856.39K |
| 2014 | -156.79% | 0.00% | 0.00x | 5.48x | $-623.62K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.23 Million |
| 2016 | -20.05% | 0.00% | 0.00x | 1.27x | $-2.31 Million |
| 2017 | -28.91% | 0.00% | 0.00x | 1.38x | $-2.09 Million |
| 2018 | -44.28% | 0.00% | 0.00x | 1.52x | $-2.23 Million |
| 2019 | -199.95% | 0.00% | 0.00x | 2.14x | $-4.68 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.03 Million |
| 2021 | -74.88% | 0.00% | 0.00x | 4.22x | $-7.09 Million |
| 2022 | -2979.46% | -2755.83% | 0.02x | 47.42x | $-13.93 Million |
| 2023 | 0.00% | -18358.00% | 0.01x | 0.00x | $-12.96 Million |
Industry Comparison
This section compares Nemaura Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nemaura Medical Inc (NMRD) | $-17.83 Million | -321.77% | N/A | $2.49K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |